12th-14th November Tokyo Big Sight
Richmond Pharmacology is attending the DIA in Tokyo 2017: Toward Valuable Medicine Developments for Patients – Expectations for the Future through Effective Utilization of Artificial Intelligence and Big Data. Dr Taubel will presenting his latest scientific poster presentation – Integration of ICH E14 Cardiac Safety in Phase I studies and Validation of Exposure-QTc Relationships.
“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”
“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”
“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”
Richmond Pharmacology CEO, Dr Jorg Taubel, Franklin Gordon, Resuscitation Simulation & Clinical Skills PractitionerRead more ›
Significant work has been undertaken to push forward the launch of a new apprentice scheme aimed at raising theRead more ›